Literature DB >> 28232454

A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition.

Anuradha Krishnan1, Tasduq Sheikh Abdullah2, Taofic Mounajjed3, Stella Hartono4, Andrea McConico5, Thomas White6, Nathan LeBrasseur6, Ian Lanza7, Sreekumaran Nair7, Gregory Gores1, Michael Charlton8,9.   

Abstract

The sequence of events that lead to inflammation and fibrosing nonalcoholic steatohepatitis (NASH) is incompletely understood. Hence, we investigated the chronology of whole body, tissue, and cellular events that occur during the evolution of diet-induced NASH. Male C57Bl/6 mice were assigned to a fast-food (FF; high calorie, high cholesterol, high fructose) or standard-chow (SC) diet over a period of 36 wk. Liver histology, body composition, mitochondrial respiration, metabolic rate, gene expression, and hepatic lipid content were analyzed. Insulin resistance [homeostasis model assessment-insulin resistance (HOMA-IR)] increased 10-fold after 4 wk. Fibrosing NASH was fully established by 16 wk. Total hepatic lipids increased by 4 wk and remained two- to threefold increased throughout. Hepatic triglycerides declined from sixfold increase at 8 wk to threefold increase by 36 wk. In contrast, hepatic cholesterol levels steadily increased from baseline at 8 wk to twofold by 36 wk. The hepatic immune cell population altered over time with macrophages persisting beyond 16 wk. Mitochondrial oxygen flux rates of FF mice diet were uniformly lower with all the tested substrates (13-276 pmol·s-1·ml-1 per unit citrate synthase) than SC mice (17-394 pmol·s-1·ml-1 per unit citrate synthase) and was accompanied by decreased mitochondrial:nuclear gene copy number ratios after 4 wk. Metabolic rate was lower in FF mice. Mitochondrial glutathione was significantly decreased at 24 wk in FF mice. Expression of dismutases and catalase was also decreased in FF mice. The evolution of NASH in the FF diet-induced model is multiphasic, particularly in terms of hepatic lipid composition. Insulin resistance precedes hepatic inflammation and fibrosis. Mitochondrial dysfunction and depletion occur after the histological features of NASH are apparent. Collectively, these observations provide a unique overview of the sequence of changes that coevolve with the histological evolution of NASH.NEW & NOTEWORTHY This study demonstrates in a first of kind longitudinal analysis, the evolution of nonalcoholic steatohepatitis (NASH) on a fast-food diet-induced model. Key findings include 1) hepatic lipid composition changes in a multiphasic fashion as NASH evolves; 2) insulin resistance precedes hepatic inflammation and fibrosis, answering a longstanding chicken-and-egg question regarding the relationship of insulin resistance to liver histology in NASH; and 3) mitochondrial dysfunction and depletion occur after the histological features of NASH are apparent.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  fatty liver; hepatic fibrosis; inflammation metabolic function; insulin resistance; mitochondrial respiration

Mesh:

Substances:

Year:  2017        PMID: 28232454      PMCID: PMC6146305          DOI: 10.1152/ajpgi.00213.2016

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  59 in total

1.  Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.

Authors:  Brent A Neuschwander-Tetri; Jeanne M Clark; Nathan M Bass; Mark L Van Natta; Aynur Unalp-Arida; James Tonascia; Claudia O Zein; Elizabeth M Brunt; David E Kleiner; Arthur J McCullough; Arun J Sanyal; Anna Mae Diehl; Joel E Lavine; Naga Chalasani; Kris V Kowdley
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

2.  Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent.

Authors:  Lay T Gan; Derrick M Van Rooyen; Mark E Koina; Robert S McCuskey; Narcissus C Teoh; Geoffrey C Farrell
Journal:  J Hepatol       Date:  2014-07-24       Impact factor: 25.083

3.  Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L-methionine and glutathione.

Authors:  Francisco Caballero; Anna Fernández; Nuria Matías; Laura Martínez; Raquel Fucho; Montserrat Elena; Joan Caballeria; Albert Morales; José C Fernández-Checa; Carmen García-Ruiz
Journal:  J Biol Chem       Date:  2010-04-15       Impact factor: 5.157

4.  Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis.

Authors:  Lars P Bechmann; Peri Kocabayoglu; Jan-Peter Sowa; Svenja Sydor; Jan Best; Martin Schlattjan; Anja Beilfuss; Johannes Schmitt; Rebekka A Hannivoort; Alpaslan Kilicarslan; Christian Rust; Frieder Berr; Oliver Tschopp; Guido Gerken; Scott L Friedman; Andreas Geier; Ali Canbay
Journal:  Hepatology       Date:  2013-04       Impact factor: 17.425

5.  Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

Authors:  Kanji Yamaguchi; Liu Yang; Shannon McCall; Jiawen Huang; Xing Xian Yu; Sanjay K Pandey; Sanjay Bhanot; Brett P Monia; Yin-Xiong Li; Anna Mae Diehl
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

6.  Mechanism of mitochondrial glutathione-dependent hepatocellular susceptibility to TNF despite NF-kappaB activation.

Authors:  Montserrat Marí; Anna Colell; Albert Morales; Francisco Caballero; Anna Moles; Anna Fernández; Oihana Terrones; Gorka Basañez; Bruno Antonsson; Carmen García-Ruiz; José C Fernández-Checa
Journal:  Gastroenterology       Date:  2008-01-31       Impact factor: 22.682

Review 7.  Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis.

Authors:  Giovanni Musso; Roberto Gambino; Maurizio Cassader
Journal:  Prog Lipid Res       Date:  2012-12-01       Impact factor: 16.195

8.  Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease.

Authors:  Hae-Ki Min; Ashwani Kapoor; Michael Fuchs; Faridoddin Mirshahi; Huiping Zhou; James Maher; John Kellum; Russell Warnick; Melissa J Contos; Arun J Sanyal
Journal:  Cell Metab       Date:  2012-05-02       Impact factor: 27.287

9.  Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease.

Authors:  Norberto C Chavez-Tapia; Natalia Rosso; Claudio Tiribelli
Journal:  BMC Gastroenterol       Date:  2012-03-01       Impact factor: 3.067

10.  High-fat diet decreases activity of the oxidative phosphorylation complexes and causes nonalcoholic steatohepatitis in mice.

Authors:  Inmaculada García-Ruiz; Pablo Solís-Muñoz; Daniel Fernández-Moreira; Montserrat Grau; Francisco Colina; Teresa Muñoz-Yagüe; José A Solís-Herruzo
Journal:  Dis Model Mech       Date:  2014-09-26       Impact factor: 5.758

View more
  28 in total

1.  Mixed Lineage Kinase 3 Mediates the Induction of CXCL10 by a STAT1-Dependent Mechanism During Hepatocyte Lipotoxicity.

Authors:  Kyoko Tomita; Ayano Kabashima; Brittany L Freeman; Steven F Bronk; Petra Hirsova; Samar H Ibrahim
Journal:  J Cell Biochem       Date:  2017-05-15       Impact factor: 4.429

2.  AGER1 downregulation associates with fibrosis in nonalcoholic steatohepatitis and type 2 diabetes.

Authors:  Ali Dehnad; Weiguo Fan; Joy X Jiang; Sarah R Fish; Yuan Li; Suvarthi Das; Gergely Mozes; Kimberly A Wong; Kristin A Olson; Gregory W Charville; Mohammed Ali; Natalie J Török
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

3.  Knockout of sulfatase 2 is associated with decreased steatohepatitis and fibrosis in a mouse model of nonalcoholic fatty liver disease.

Authors:  Tae Hyo Kim; Bubu A Banini; Faizal Z Asumda; Nellie A Campbell; Chunling Hu; Catherine D Moser; Abdirashid M Shire; Shaoshan Han; Chenchao Ma; Anuradha Krishnan; Taofic Mounajjed; Thomas A White; Gregory J Gores; Nathan K LeBrasseur; Michael R Charlton; Lewis Rowland Roberts
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-07-20       Impact factor: 4.052

4.  Diet Mimicking "Fast Food" Causes Structural Changes to the Retina Relevant to Age-Related Macular Degeneration.

Authors:  Gavin W Roddy; Robert H Rosa; Kimberly B Viker; Bradley H Holman; Cheryl R Hann; Anuradha Krishnan; Gregory J Gores; Sophie J Bakri; Michael P Fautsch
Journal:  Curr Eye Res       Date:  2019-12-02       Impact factor: 2.424

5.  Vertical Sleeve Gastrectomy Attenuates the Progression of Non-Alcoholic Steatohepatitis in Mice on a High-Fat High-Cholesterol Diet.

Authors:  Emily Whang; Yuan Liu; Shoichi Kageyama; Shih Lung Woo; Jieping Yang; Rupo Lee; Zhaoping Li; Haofeng Ji; Yijun Chen; Jerzy W Kupiec-Weglinski
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

6.  Lipid-induced endothelial vascular cell adhesion molecule 1 promotes nonalcoholic steatohepatitis pathogenesis.

Authors:  Kunimaro Furuta; Qianqian Guo; Kevin D Pavelko; Jeong-Heon Lee; Keith D Robertson; Yasuhiko Nakao; Jan Melek; Vijay H Shah; Petra Hirsova; Samar H Ibrahim
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

Review 7.  Animal Models of Fibrosis in Nonalcoholic Steatohepatitis: Do They Reflect Human Disease?

Authors:  David H Ipsen; Jens Lykkesfeldt; Pernille Tveden-Nyborg
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

8.  Western Diet Decreases the Liver Mitochondrial Oxidative Flux of Succinate: Insight from a Murine NAFLD Model.

Authors:  Pavla Staňková; Otto Kučera; Eva Peterová; Moustafa Elkalaf; David Rychtrmoc; Jan Melek; Miroslav Podhola; Veronika Zubáňová; Zuzana Červinková
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

9.  The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Shelley E Harris; Toryn M Poolman; Anastasia Arvaniti; Roger D Cox; Laura L Gathercole; Jeremy W Tomlinson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-08-05       Impact factor: 4.052

10.  Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.

Authors:  Kirstine S Tølbøl; Maria Nb Kristiansen; Henrik H Hansen; Sanne S Veidal; Kristoffer Tg Rigbolt; Matthew P Gillum; Jacob Jelsing; Niels Vrang; Michael Feigh
Journal:  World J Gastroenterol       Date:  2018-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.